期刊文献+

降糖消脂片对糖尿病动物降糖作用的研究 被引量:8

Study of Jiangtang Xiaozhi Tablets on Decreasing of Blood Glucose in Rat and Mouse Models of Diabetes Mellitus
原文传递
导出
摘要 目的:采用糖尿病大、小鼠模型,观察降糖消脂片的降糖作用。方法:大鼠用链脲佐菌素iv造模(50 mg·kg-1)。小鼠用四氧嘧啶iv造模(90 mg.kg-1)。3 d后测血糖,筛选成模动物。大鼠分为7组,12只/组。连续ig降糖消脂片8,4,2 g·kg-1 8周,测定血糖、糖化血红蛋白、胰岛素、胰高血糖素等指标。小鼠分为7组,14只/组。连续ig降糖消脂片10,5,2.5 g·kg-1 4周,测血糖。结果:糖尿病模型大鼠在连续ig 8周后,降糖消脂片各剂量组与模型组比较,血糖明显降低(P<0.05);高剂量组糖化血红蛋白、胰高血糖素明显下降(P<0.05),胰岛素水平有增高的趋势;胰腺病理结果显示:降糖消脂片高剂量组胰岛数目明显增多。糖尿病小鼠模型在连续ig 4周后,降糖消脂片高、中剂量组血糖明显降低(P<0.05~0.001)。结论:降糖消脂片对糖尿病大、小鼠均有明显降糖作用。 Objective:To observe effects of Jiangtang xiaozhi Tablets on decreasing levels of blood glucose in rat and mouse models of diabetes mellitus.Method:Rats were intravenously given streptozotocin at dose of 50 mg·kg^-1.Mice were intravenously given Alloxan at dose of 90 mg·kg^-1to induce hyperglycemia.The levels of blood glucose in the rats and mice were measured after 3 days for screening model animals.Thereafter,rats were divided into 7 groups(n = 12,each) and were continuously given Jiangtang xiaozhi tablets by intragastric administration for 8 weeks.The levels of blood glucose,HBAlc,insulin and glucagon were assayed.While mice were divided into 7 groups(n=14,each) and were continuously given Jiangtang xiaozhi tablets by intragastric administration for 4 weeks.The level of blood glucose was assayed.Result: The levels of blood glucose in each Jiangtang xiaozhi treatment group,HBAlc and glucagon levels in high dose group were significantly decreased(P〈0.05) comparing to those of model rats while serum insulin levels were increased in the high dose group.The morphological study of pancreas in rats demonstrated that number of islets markedly increased in the high dose group.The levels of blood glucose in mice were significantly decreased(P〈0.05-0.001) in middle and high dose groups comparing to that of model mice.Conclusion:Jiangtang xiaozhi Tablets has obvious effect on decreasing blood glucose for model animals of diabetes mellites.
出处 《中国实验方剂学杂志》 CAS 北大核心 2010年第16期143-146,共4页 Chinese Journal of Experimental Traditional Medical Formulae
基金 综合性中药新药研究开发技术大平台(2009ZX09303-003) 重大新药创制-中药医院制剂新药研发(2010ZX09102-213)
关键词 链脲佐菌素 四氧嘧啶 动物模型 胰岛素 糖化血红蛋白 streptozotocin alloxan animal model insulin HBAlc
  • 相关文献

参考文献3

二级参考文献31

  • 1李才,邓义斌,王丽娟,张秀云,邹雅斌,侯芳玉.实验性糖尿病大鼠肾脏自由基防御机能的改变及其意义[J].中国病理生理杂志,1995,11(6):638-641. 被引量:32
  • 2于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 3张子臻.女贞子能降血脂,改善心肌供血[J].中医杂志,1998,39(9):518-518.
  • 4肖小河,苏中武,乔传卓,罗泽渊.姜黄属药用植物研究进展[J].中草药,1997,28(2):114-119. 被引量:72
  • 5Ha H,Lee HB.Reactive oxygen species as glucose signaling molecules in mesangial cells cultured under high glucose[J].Kidney Int Suppl,2000,77(1):S19.
  • 6Masuda T.Chemical studies on antioxidant mechanism of curcuminoid:analysis of radical reaction products from curcumin[J].J Agric Food Chem,1999,47(1):71.
  • 7Suresh Babu P,Srinivasan K.Hypolipidemic action of curcumin,the active principle of turmeric(Curcuma Longa)in streptozotocin induced diabetic rats[J].Mol Cell Biochem,1997,166(1—2):169.
  • 8Arun N,Nalini N.Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats[J].Plant Foods Hum Nutr.2002,57(1):41.
  • 9Onozato ML,Tojo A,Goto A,et a1.Oxidative stress and nitric oxide synthase in rat diabetic nephropathy,effect of ACEI and ARB[J].Kidney Int,2002,61(1):186.
  • 10Lee HB,Yu MR,Yang Y,et a1.Reactive oxygen species—regulated signaling pathways in diabetic nephropathy[J].J Am Soc Nephrol,2003,14(8 Suppl 3):S241.

共引文献119

同被引文献51

  • 1于冬青,邓华聪.姜黄素对糖尿病大鼠糖、脂代谢及氧化应激的影响[J].重庆医学,2005,34(1):37-39. 被引量:25
  • 2郭清华,陆菊明,潘长玉.饮食能量对Kkay及Kk小鼠2型糖尿病发病的影响[J].军医进修学院学报,2005,26(2):140-142. 被引量:18
  • 3尚敬,孙晖,肖方喜,陈璐璐.清醒状态下大鼠尾动静脉插管高胰岛素-正糖钳夹实验[J].上海交通大学学报(医学版),2006,26(9):968-971. 被引量:11
  • 4陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2010:282.
  • 5Stitt A, Gardiner TA, Alderson NL, et al. The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes[J]. Diabetes, 2002,51(9): 2826-2832.
  • 6Robison WG, Laver NM, Jacot JL, et al. Efficacy of treatment after measurable diabeticlike retinopathy in galactose-fed rats[J]. Invest Opthalmol vis Sci, 1997,38(6): 1066-1073.
  • 7Hanmes HP, Lin J, Wagner P, et al. Angiopoietin 2 causes pericyte dropout in the normai retina evidence for involvement in diabetic retinopathy[J]. Diabetes, 2004,53(4): 1104-1110.
  • 8Marshail SM, Flyvbjerg A. Prevention and early detection of vascular complications of diabetes[J]. BMJ, 2006,333: 475-480.
  • 9Klein R, Klein BE, Moss SE. Epidemiology of proliferative diabetic retinopathy[J]. Diabetes Care, 1992,15: 1875-1891.
  • 10David AA, Ronald K, Thomas WG. Diabetic Retinopathy[J]. N Engl J Med, 2012,366: 1227-1239.

引证文献8

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部